CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

BlueCross BlueShield of Arizona

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
D
Index (ASP = 100)
83.0
Vs. acquisition
-19.2%
Brand index
83.0
Biosimilar index
84.2
Contract variability
Medium
Drugs observed
883
States
19

Contracts below the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 9 distinct contracted rates across practices, with 31% of billing volume on the single most common rate — a dispersed, negotiated book.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.